Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Biotech Australia, a subsidiary of GroPrep Ltd., is an Australian company that develops medicines and technologies used for targeting specific diseases. It was acquired by GroPrep Ltd. on February 27, 2002.

Pantarhei Bioscience BV (PRB) is a limited liability company (Besloten Vennootschap) located in the Netherlands focussing on the development of innovative concepts for woman’s health and hormone-related cancer treatments. PRB has founded a subsidiary company – Pantarhei Oncology (PRO) – to develop treatments for Endocrine Cancer. PRB has developed a product pipeline based on its ability to identify novel medical uses of existing molecules, drugs, hormones, biologicals and combinations thereof in these areas of medicine. The main areas of expertise of PRB are reproductive hormone related treatments and diseases such as contraception and menopausal hormone therapy (MHT). The main areas of expertise of PRO are breast cancer, prostate cancer and ovarian cancer . PRB develops patent protected new treatment concepts up to proof-of-concept (PoC) in the human (phase II). Using existing molecules often provides first evidence of safety. The business model of the Pantarhei companies is based on creating intellectual property (IP) of new concepts ad inventions, in-house project management and outsourcing of all research and development activities. After successful PoC, data and IP are licensed out to a licensee or partner for completion of clinical development (phase III), regulatory approval and sales and marketing by a licensee/partner.

Manufactures pharmaceuticals

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Manufactures and supplies monosodium glutamate and related additives

Sandoz AG, part of Novartis AG, is a company headquartered in Basel, Switzerland, that develops generic medicines and biosimilars.

Princeton BioMeditech Corp. researches and develops diagnostics medical solutions. Its products include cardiac marker, drugs of abuse, tumor maker, veterinary diagnostics instruments and full product catalog. The company was founded by Jemo Kang in 1988 and is headquartered in Monmouth Junction, NJ

Istituto Farmacologico Serono is a private company headquartered in Rome, Italy, that manufactures and distributes pharmaceutical products.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

Monash Medical Centre (MMC) is a teaching hospital in Melbourne, Australia. It provides specialist tertiary-level healthcare to the Melbourne's south-east. Monash Medical Centre is part of Monash Health, the largest public health service in Victoria.

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Undbio develops pharmaceuticals to treat diabetes, cancer, and immunology related diseases.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Zhe Jiang Shi Jia Sheng Wu Yi Liao You Xian Gong Si, established on 2002-08-01, Business scope includes design,manufacture,repair:second category6820General diagnostic equipment,Class II and Class III6854operating room,emergency room,Consulting room equipment and appliances,Class II and Class III6840Clinical Laboratory Analytical Instruments,Class II and Class III6840In vitro diagnostic reagents,Second and third types of in vitro diagnostic reagents supporting biological materials,injection molding,mold,Thermometers,breast pump;wholesale,retail:Instrumentation,medical instruments(Limited to one category,Class II),Class III medical device,Baby Products(except food,medicine),electronic product(In addition to exclusive control),Electronic Component;Import and export(National law,Except for items prohibited by administrative regulations,law,Projects restricted by administrative regulations can only be operated after obtaining a license);All other legal items that do not need to be submitted for approval.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Chengdu Aiweifu Biotechnology Co., Ltd., established on 2017-01-25, Business scope includes biotechnology development,technical consulting,Technical Services,technology transfer;software development;Instrumentation,chemical reagent,Polymer Materials,Research and development of active equipment and consumables,Production,Sales;Medical device research and development.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).Medical device production,Sales.(Did not obtain the relevant administrative license(approval),Do not carry out business activities).